Physician profile
Michael B Freeman
NPI 1396769717
$1,516.74
in general payments reported to CMS, 2019-2025
10 companies · $72.24 in 2025
The $72.24 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.56 · 2020: $72.92 · 2021: $325 · 2022: $563 · 2023: $243 · 2024: $146 · 2025: $72.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $597.99 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Stryker Corporation | $234.01 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $222.48 | 2022-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Janssen Pharmaceuticals, INC | $150.76 | 2020-2022 | |
| Cochlear Americas | $145.71 | 2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Medtronic USA, INC. | $56.24 | 2020 | |
| Davol INC. | $37.31 | 2024 | |
| Atricure, INC. | $25.26 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Cagent Vascular INC | $23.70 | 2025 | Serrantor |
| Abbott Laboratories | $23.28 | 2025 | Esprit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.